Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6250190 | The Journal of Sexual Medicine | 2016 | 12 Pages |
Abstract
For sexual problems, the treatment of VVA remains the most pertinent indication for estrogen therapy. When systemic symptoms are absent, estrogen therapy ideally can be administered by a vaginal preparation alone. Systemic estrogen therapy with combined estrogen and progestin in non-hysterectomized women is indicated for women who require treatment for vasomotor and/or other systemic estrogen deficiency symptoms. The improvement in well-being achieved by relief of vasomotor and other symptoms might improve libido in some women and abrogate further intervention.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Nanette MD, Roisin MBBS, FRACP, Karen K. MD, Sharon J. MD, Susan R. MBBS, FRACP, PhD,